511296-88-1,
Cyclic pifithrin-alpha hydrobromide,
Pifithrin-beta hydrobromide,
Pifithrin-|A hydrobromide,
Pifithrin-alpha, Cyclic-,
QB102,
UNII-UP003XXT4D,
UP003XXT4D,
Cyclic Pifithrin-|A hydrobromide,
HY-16702A,
MFCD02683960,
2-(4-Methylphenyl)imidazo[2,1-b]-5,6,7,8-tetrahydrobenzothiazole, HBr,
2-(4-methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole;hydrobromide,
2-(4-Methylphenyl)imidazo[2,1-b]-5,6,7,8-tetrahydrobenzothiazole hydrobromide,
Pifithrin-beta hydrobromide [MI],
Cyclic PFT-|A,
cyclic-pifithrin-alpha,
Pifithrin-|A, cyclic,
Pifithrin-alpha, cyclic,
Cyclic PFT-|A hydrobromide,
cyclic-pifithrin-hydrobromide,
Cyclic PFT-alpha hydrobromide,
Cyclic Pifithrin- hydrobromide,
CHEMBL540356,
Cyclic Pifithrin-? hydrobromide,
CTK8G2421,
BCP17578,
Cyclic Pifithrin-I+/- hydrobromide,
EX-A1163,
HY16702A,
KS-00000TI4,
AKOS024457829,
CS-3371,
5,6,7,8-Tetrahydro-2-(4-methylphenyl)-imidazo[2,1-b]benzothiazolehydrobromide,
5,6,7,8-Tetrahydro-2-(4-methylphenyl)imidazo(2,1-b)benzothiazole hydrobromide,
Imidazo(2,1-b)benzothiazole, 5,6,7,8-tetrahydro-2-(4-methylphenyl)-, hydrobromide (1:1),
AK213375,
BC600658,
Cyclic Pifithrin-alpha hydrobromide, >=98% (HPLC),
2-(p-Tolyl)-5,6,7,8-tetrahydroimidazo[2,1-b]benzothiazole Hydrobromide,
5,6,7,8-Tetrahydro-2-(4-methylphenyl)-imidazo[2,1-b]benzothiazole hydrobromide,
5,6,7,8-TETRAHYDRO-2-(4-METHYLPHENYL)-IMIDAZO[2,1-B]BENZOTHIAZOLEHBR,
4-(4-methylphenyl)-7-thia-2,5-diazatricyclo[6.4.0.0?,?]dodeca-1(8),3,5-triene hydrobromide,
Pifithrin-AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade markAfA centA centasA notA em leaderA inverted exclamation mark (hydrobromide),
Pifithrin-Beta,
Pifithrin-?,
Pifithrin-|A,
Pifithrin-|A (hydrobromide),
PFT-|A,
Cyclic Pifithrin-Alpha (Hydrobromide),
CID11515812,
CID 11515812,
C2826,
A12450,
60477-34-1,